Trump announces deals with pharma companies to lower drug prices to global rates.

US President Donald Trump announced agreements with 17 major pharmaceutical companies, covering about 86% of the branded drug market, to lower prescription drug prices by aligning them with the lowest global rates. The deals include steep cuts on key medications, such as a cholesterol drug dropping from $537 to $225 per month. The administration claims this represents the largest price reduction in U.S. history and aims to strengthen domestic manufacturing.